Publications

• COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid.
  J Thromb Haemost Volume: 20 Page(s): 2909 - 2920
  12/01/2022 Authors: Moiseiwitsch N; Zwennes N; Szlam F; Sniecinski R; Brown A
• COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography.
  J Thromb Thrombolysis Volume: 52 Page(s): 766 - 771
  10/01/2021 Authors: Maier CL; Sarker T; Szlam F; Sniecinski RM
• Identification of coagulation factor IX variants with enhanced activity through ancestral sequence reconstruction.
  Blood Adv Volume: 5 Page(s): 3333 - 3343
  09/14/2021 Authors: Knight KA; Coyle CW; Radford CE; Parker ET; Fedanov A; Shields JM; Szlam F; Purchel A; Chen M; Denning G
• Controlled Multifactorial Coagulopathy: Effects of Dilution, Hypothermia, and Acidosis on Thrombin Generation In Vitro.
  Anesth Analg Volume: 130 Page(s): 1063 - 1076
  04/01/2020 Authors: Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
• Platelet function, but not thrombin generation, is impaired in acute normovolemic hemodilution (ANH) blood.
  J Clin Anesth Volume: 58 Page(s): 39 - 43
  12/01/2019 Authors: Scott KJ; Shteamer JW; Szlam F; Sniecinski RM
• DECREASED THROMBIN INHIBITION WITH HYPOTHERMIA AS MEASURED BY CALIBRATED AUTOMATED THROMBOGRAPHY (CAT)
  Volume: 128 Page(s): 981 - 982
  05/01/2019 Authors: Sniecinski R; Szlam F; Mitrophanov AY; Reifman J
• Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgery.
  Transfusion Volume: 59 Page(s): 1209 - 1222
  04/01/2019 Authors: Spinella PC; Sniecinski RM; Trachtenberg F; Inglis HC; Ranganathan G; Heitman JW; Szlam F; Danesh A; Stone M; Keating SM
• Influence of Blood Storage Age on Immune and Coagulation Parameters in Critically Ill or Cardiac Surgery Patients Receiving Transfusion
  Volume: 58 Page(s): 46A - 46A
  10/01/2018 Authors: Norris PJ; Schechtman K; Sniecinski R; Trachtenberg F; Ranganathan G; Adelman A; Keating S; Cohen M; Szlam F; Levy J
• In Response.
  Anesth Analg Volume: 124 Page(s): 702
  02/01/2017 Authors: Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
• In Response.
  Anesth Analg Volume: 124 Page(s): 699 - 700
  02/01/2017 Authors: Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
• A Step Toward Balance: Thrombin Generation Improvement via Procoagulant Factor and Antithrombin Supplementation.
  Anesth Analg Volume: 123 Page(s): 535 - 546
  09/01/2016 Authors: Mitrophanov AY; Szlam F; Sniecinski RM; Levy JH; Reifman J
• Computational simulation and comparison of prothrombin complex concentrate dosing schemes for warfarin reversal in cardiac surgery.
  J Anesth Volume: 30 Page(s): 369 - 376
  06/01/2016 Authors: Tanaka KA; Mazzeffi MA; Strauss ER; Szlam F; Guzzetta NA
• Optimizing Thrombin Generation with 4-Factor Prothrombin Complex Concentrates in Neonatal Plasma After Cardiopulmonary Bypass.
  Anesth Analg Volume: 122 Page(s): 935 - 942
  04/01/2016 Authors: Franklin SW; Szlam F; Fernandez JD; Leong T; Tanaka KA; Guzzetta NA
• Differential Contributions of Intrinsic and Extrinsic Pathways to Thrombin Generation in Adult, Maternal and Cord Plasma Samples.
  PLoS One Volume: 11 Page(s): e0154127
  01/01/2016 Authors: Rice NT; Szlam F; Varner JD; Bernstein PS; Szlam AD; Tanaka KA
• Effects of a plasma-derived C1 esterase inhibitor on hemostatic activation, clot formation, and thrombin generation.
  Blood Coagul Fibrinolysis Volume: 25 Page(s): 883 - 889
  12/01/2014 Authors: Levy JH; Szlam F; Gelone S
• Effects of a plasma-derived C1 esterase inhibitor on hemostatic activation, clot formation, and thrombin generation
  BLOOD COAGULATION & FIBRINOLYSIS Volume: 25 Page(s): 883 - 889
  12/01/2014 Authors: Levy JH; Szlam F; Gelone S
• Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a review of the literature and current guidelines for testing.
  Clin Lab Med Volume: 34 Page(s): 453 - 477
  09/01/2014 Authors: Levy JH; Szlam F; Wolberg AS; Winkler A
• Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.
  Br J Anaesth Volume: 112 Page(s): 319 - 327
  02/01/2014 Authors: Guzzetta NA; Szlam F; Kiser AS; Fernandez JD; Szlam AD; Leong T; Tanaka KA
• Transfusion and hematologic variables after fibrinogen or platelet transfusion in valve replacement surgery: preliminary data of purified lyophilized human fibrinogen concentrate versus conventional transfusion.
  Transfusion Volume: 54 Page(s): 109 - 118
  01/01/2014 Authors: Tanaka KA; Egan K; Szlam F; Ogawa S; Roback JD; Sreeram G; Guyton RA; Chen EP
• Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions.
  Br J Anaesth Volume: 111 Page(s): 1013 - 1023
  12/01/2013 Authors: Ogawa S; Ohnishi T; Hosokawa K; Szlam F; Chen EP; Tanaka KA
• In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel.
  Thromb Res Volume: 132 Page(s): 106 - 111
  07/01/2013 Authors: Mazzeffi M; Szlam F; Jakubowski JA; Tanaka KA; Sugidachi A; Levy JH
• An ex vivo evaluation of the hemostatic effects of plasma-derived C1 inhibitor
  JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 11 Page(s): 854 - 854
  07/01/2013 Authors: Levy JH; Szlam F; Gelone S
• Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mouse and anti-factor IXa-treated human blood.
  Haemophilia Volume: 18 Page(s): 926 - 932
  11/01/2012 Authors: Ogawa S; Szlam F; Dunn AL; Bolliger D; Ohnishi T; Hosokawa K; Tanaka KA
• The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
  Anesth Analg Volume: 115 Page(s): 244 - 252
  08/01/2012 Authors: Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
• Platelet procoagulant activity and thrombin generation in patients with severe hemophilia
  HAEMOPHILIA Volume: 18 Page(s): 42 - 42
  07/01/2012 Authors: Dunn A; Taylor L; Neisler J; Zhou C; Szlam F; Tanaka K; Jobe S
• THROMBIN GENERATION AND PLATELET PROCOAGULANT ACTIVITY IN SEVERE HEMOPHILIA
  PEDIATRIC BLOOD & CANCER Volume: 58 Page(s): 1030 - 1031
  07/01/2012 Authors: Taylor L; Neisler J; Zhou C; Szlam F; Tanaka K; Dunn A; Jobe S
• The impact of hematocrit on fibrin clot formation assessed by rotational thromboelastometry.
  Anesth Analg Volume: 115 Page(s): 16 - 21
  07/01/2012 Authors: Ogawa S; Szlam F; Bolliger D; Nishimura T; Chen EP; Tanaka KA
• Development of a fast and simple liquid chromatography-tandem mass spectrometry method for the quantitation of argatroban in patient plasma samples.
  J Chromatogr B Analyt Technol Biomed Life Sci Volume: 893-894 Page(s): 168 - 172
  04/15/2012 Authors: Rhea JM; Snyder ML; Winkler AM; Abou-Diwan C; Fantz CR; Ritchie JC; Szlam F; Tanaka KA; Molinaro RJ
• Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
  Anesth Analg Volume: 114 Page(s): 261 - 274
  02/01/2012 Authors: Levy JH; Szlam F; Tanaka KA; Sniecienski RM
• A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery.
  Transfusion Volume: 52 Page(s): 14 - 22
  01/01/2012 Authors: Ogawa S; Szlam F; Chen EP; Nishimura T; Kim H; Roback JD; Levy JH; Tanaka KA
• A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
  Thromb Haemost Volume: 106 Page(s): 1215 - 1223
  12/01/2011 Authors: Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA
• Rotation thromboelastometry for a rapid assessment of plasma fibrinogen during cardiopulmonary bypass surgery
  JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 9 Page(s): 700 - 701
  07/01/2011 Authors: Ogawa S; Szlam F; Levy JH; Tanaka KA
• In vitro thienopyridines' effects on platelet procoagulant activity: rFVIIa alone or with ADP offsets thrombin generation inhibition mediated by Prasugrel's active metabolite
  JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 9 Page(s): 335 - 336
  07/01/2011 Authors: Levy JH; Szlam F; Kim H; Ogawa S; Jakubowski JA; Sugidachi A; Tanaka KA
• Does fibrinogen replacement increase the risk of vascular occlusion after cardiac surgery?
  JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 9 Page(s): 480 - 480
  07/01/2011 Authors: Tanaka K; Ogawa S; Szlam F; Levy JH; Ohnishi T; Hosokawa K
• Fibrinolytic effects of factor XIII inhibition are potentiated by tissue plasminogen activator
  JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 9 Page(s): 384 - 384
  07/01/2011 Authors: Levy JH; Szlam F; Kim H; Tanaka K; Ogawa S; Hils M; Pasternack R
• Effects of MDCO-2010 on activated clotting time in blood obtained from patients undergoing cardiopulmonary bypass
  JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 9 Page(s): 574 - 575
  07/01/2011 Authors: Kim H; Szlam F; Tanaka K; Ogawa S; van de Locht A; Levy JH
• Evaluation of a novel flow chamber system to assess clot formation in factor VIII-deficient mice
  JOURNAL OF THROMBOSIS AND HAEMOSTASIS Volume: 9 Page(s): 701 - 702
  07/01/2011 Authors: Ogawa S; Szlam F; Ohnishi T; Hosokawa K; Kenichi TA
• Plasma and cerebral spinal fluid tranexamic acid quantitation in cardiopulmonary bypass patients.
  J Chromatogr B Analyt Technol Biomed Life Sci Volume: 879 Page(s): 553 - 556
  03/01/2011 Authors: Abou-Diwan C; Sniecinski RM; Szlam F; Ritchie JC; Rhea JM; Tanaka KA; Molinaro RJ
• Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.
  Thromb Res Volume: 127 Page(s): 135 - 140
  02/01/2011 Authors: Szlam F; Sreeram G; Solomon C; Levy JH; Molinaro RJ; Tanaka KA
• Argatroban "reversal" is caused by nonphysiologic stimulation of coagulation, not activated factor VII.
  J Cardiothorac Vasc Anesth Volume: 24 Page(s): 1026 - 1027
  12/01/2010 Authors: Tanaka KA; Szlam F; Koyama K; Levy JH
• Treatment of massive bleeding with prothrombin complex concentrate: argument for.
  J Thromb Haemost Volume: 8 Page(s): 2589 - 2591
  12/01/2010 Authors: Tanaka KA; Szlam F
• Ensembles of uncertain mathematical models can identify network response to therapeutic interventions.
  Mol Biosyst Volume: 6 Page(s): 2272 - 2286
  11/01/2010 Authors: Luan D; Szlam F; Tanaka KA; Barie PS; Varner JD
• The anticoagulant effect of protamine sulfate is attenuated in the presence of platelets or elevated factor VIII concentrations.
  Anesth Analg Volume: 111 Page(s): 601 - 608
  09/01/2010 Authors: Bolliger D; Szlam F; Azran M; Koyama K; Levy JH; Molinaro RJ; Tanaka KA
• In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma.
  J Cardiothorac Vasc Anesth Volume: 24 Page(s): 408 - 412
  06/01/2010 Authors: Rumph B; Bolliger D; Narang N; Molinaro RJ; Levy JH; Szlam F; Tanaka KA
• Heterozygous antithrombin deficiency improves in vivo haemostasis in factor VIII-deficient mice.
  Thromb Haemost Volume: 103 Page(s): 1233 - 1238
  06/01/2010 Authors: Bolliger D; Szlam F; Suzuki N; Matsushita T; Tanaka KA
• Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
  Haemophilia Volume: 16 Page(s): 510 - 517
  05/01/2010 Authors: Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
• Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa. (vol 16, pg 510, 2010)
  HAEMOPHILIA Volume: 16 Page(s): 567 - 567
  05/01/2010 Authors: Bolliger D; Szlam F; Molinaro RJ; Escobar MA; Levy JH; Tanaka KA
• Anti-factor IXa Aptamer reduces propagation of thrombin generation in plasma anticoagulated with warfarin.
  Thromb Res Volume: 125 Page(s): 432 - 437
  05/01/2010 Authors: Szlam F; Luan D; Bolliger D; Szlam AD; Levy JH; Varner JD; Tanaka KA
• In vitro effects of recombinant activated factor VIIa (NovoSeven) on clopidogrel-induced platelet inhibition.
  Thromb Haemost Volume: 103 Page(s): 863 - 865
  04/01/2010 Authors: Szlam F; Tanaka KA; Rumph B; Bolliger D; Levy JH
• Haemodilution-induced profibrinolytic state is mitigated by fresh-frozen plasma: implications for early haemostatic intervention in massive haemorrhage.
  Br J Anaesth Volume: 104 Page(s): 318 - 325
  03/01/2010 Authors: Bolliger D; Szlam F; Levy JH; Molinaro RJ; Tanaka KA
• Prophylactic use of factor IX concentrate in a Jehovah's Witness patient.
  Ann Thorac Surg Volume: 88 Page(s): 1666 - 1668
  11/01/2009 Authors: Bolliger D; Sreeram G; Duncan A; Molinaro RJ; Szlam F; Chen EP; Tanaka KA
• Protamine inhibits conversion of prothrombin to thrombin
  SWISS MEDICAL WEEKLY Volume: 139 Page(s): 18S - 18S
  10/17/2009 Authors: Bolliger D; Szlam F; Levy JH; Tanaka KA
• Can we reverse clopidogrel-induced platelet dysfunction?
  Volume: 7 Page(s): 586 - 586
  07/01/2009 Authors: Szlam F; Tanaka KA; Bolliger D; Rumph B; Levy JH
• Hemostatic management in Jehovah's Witness patient undergoing complex cardiac surgery
  Volume: 7 Page(s): 550 - 550
  07/01/2009 Authors: Bolliger D; Sreeram G; Molinaro RJ; Szlam F; Chen EP; Tanaka KA
• Protamine inhibits propagation of thrombin generation
  Volume: 7 Page(s): 689 - 690
  07/01/2009 Authors: Tanaka KA; Bolliger D; Levy JH; Szlam F
• Optimal Dosage for Fibrinogen Substitution After Severe Hemodilution In Vitro
  Volume: 55 Page(s): A78 - A78
  06/01/2009 Authors: Molinaro RJ; Bolliger D; Szlam F; Levy J; Tanaka K
• Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model.
  Br J Anaesth Volume: 102 Page(s): 793 - 799
  06/01/2009 Authors: Bolliger D; Szlam F; Molinaro RJ; Rahe-Meyer N; Levy JH; Tanaka KA
• In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometry.
  Thromb Haemost Volume: 101 Page(s): 827 - 833
  05/01/2009 Authors: Tanaka KA; Szlam F; Rusconi CP; Levy JH
• Antifibrinolytic agents reduce tissue plasminogen activator-mediated neuronal toxicity in vitro.
  Acta Anaesthesiol Scand Volume: 53 Page(s): 325 - 331
  03/01/2009 Authors: Sun H-Y; Szlam F; Levy JH; Csete ME; Tanaka KA
• Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin.
  Anesthesiology Volume: 109 Page(s): 160 - 161
  07/01/2008 Authors: Molinaro RJ; Szlam F; Levy JH; Fantz CR; Tanaka KA
• Interaction between thrombin mutant W215A/E217A and direct thrombin inhibitor.
  Blood Coagul Fibrinolysis Volume: 19 Page(s): 465 - 468
  07/01/2008 Authors: Tanaka KA; Gruber A; Szlam F; Bush LA; Hanson SR; Di Cera E
• Effects of direct thrombin inhibitors on modified Clauss methods for fibrinogen and associated low plasma fibrinogen levels during anticoagulation with bivalirudin
  Volume: 54 Page(s): A226 - A226
  06/01/2008 Authors: Molinaro RJ; Szlam F; Fantz CR; Tanaka KA
• Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
  Anesth Analg Volume: 106 Page(s): 719 - 724
  03/01/2008 Authors: Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA
• Improved clot formation by combined administration of activated factor VII (NovoSeven) and fibrinogen (Haemocomplettan P).
  Anesth Analg Volume: 106 Page(s): 732 - 738
  03/01/2008 Authors: Tanaka KA; Taketomi T; Szlam F; Calatzis A; Levy JH
• Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
  Blood Coagul Fibrinolysis Volume: 19 Page(s): 135 - 141
  03/01/2008 Authors: Taketomi T; Szlam F; Bader SO; Sheppard CA; Levy JH; Tanaka KA
• Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass.
  Anesth Analg Volume: 106 Page(s): 713 - 718
  03/01/2008 Authors: Sniecinski R; Szlam F; Chen EP; Bader SO; Levy JH; Tanaka KA
• A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
  Anesth Analg Volume: 106 Page(s): 419 - 425
  02/01/2008 Authors: Guzzetta NA; Bajaj T; Fazlollah T; Szlam F; Wilson E; Kaiser A; Tosone SR; Miller BE
• Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation.
  Thromb Res Volume: 122 Page(s): 117 - 123
  01/01/2008 Authors: Tanaka KA; Szlam F; Dickneite G; Levy JH
• Warfarin reversal with prothrombin complex concentrate confers better antifibrinolytic activity compared with recombinant activated factor VII.
  Blood Coagul Fibrinolysis Volume: 19 Page(s): 106 - 108
  01/01/2008 Authors: Taketomi T; Szlam F; Levy JH; Tanaka KA
• Thrombin-activated thrombelastography for evaluation of thrombin interaction with thrombin inhibitors.
  Blood Coagul Fibrinolysis Volume: 18 Page(s): 761 - 767
  12/01/2007 Authors: Taketomi T; Szlam F; Vinten-Johansen J; Levy JH; Tanaka KA
• Evaluation of the REG1 anticoagulant system using Thrombelastography and thrombin generation assay
  Volume: 110 Page(s): 71B - 71B
  11/16/2007 Authors: Tanaka KA; Szlam F; Rusconi CP; Levy JH
• Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.
  Anesth Analg Volume: 105 Page(s): 933 - 939
  10/01/2007 Authors: Tanaka KA; Szlam F; Sun HY; Taketomi T; Levy JH
• Comparison of relaxation responses to multiple vasodilators in TxA(2)-analog and endothelin-1-precontracted pulmonary arteries.
  Acta Anaesthesiol Scand Volume: 51 Page(s): 714 - 721
  07/01/2007 Authors: Piamsomboon C; Tanaka KA; Szlam F; Makita T; Huraux C; Levy JH
• Coagulopathy after cardiopulmonary bypass in Jehovah's Witness patients: management of two cases using fractionated components and factor VIIa.
  Anesth Analg Volume: 104 Page(s): 763 - 765
  04/01/2007 Authors: Sniecinski RM; Chen EP; Levy JH; Szlam F; Tanaka KA
• Clinical measures of heparin's effect and thrombin inhibitor levels in pediatric patients with congenital heart disease.
  Anesth Analg Volume: 103 Page(s): 1131 - 1138
  11/01/2006 Authors: Guzzetta NA; Miller BE; Todd K; Szlam F; Moore RH; Brosius KK; Wilson EC; Cohen AM; Tosone SR
• Tissue plasminogen activator and thrombin generation measurements using the Thrombinoscope.
  Blood Coagul Fibrinolysis Volume: 17 Page(s): 603 - 604
  10/01/2006 Authors: Szlam F; Levy JH; Tanaka KA
• The interaction of active-site blocked thrombin and bivalirudin
  Volume: 4 Page(s): 152 - 152
  10/01/2006 Authors: Tanaka K; Szlam F; Taketomi T; Levy J
• The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation.
  Br J Haematol Volume: 134 Page(s): 77 - 82
  07/01/2006 Authors: Tanaka KA; Szlam F; Levy JH
• Effects of antithrombin and heparin cofactor II levels on anticoagulation with Intimatan.
  Thromb Haemost Volume: 94 Page(s): 808 - 813
  10/01/2005 Authors: Tanaka KA; Szlam F; Vinten-Johansen J; Cardin AD; Levy JH
• The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography.
  Anesth Analg Volume: 100 Page(s): 1781 - 1785
  06/01/2005 Authors: Katori N; Tanaka KA; Szlam F; Levy JH
• An evaluation of the effects of a standard heparin dose on thrombin inhibition during cardiopulmonary bypass in neonates.
  Anesth Analg Volume: 100 Page(s): 1276 - 1282
  05/01/2005 Authors: Guzzetta NA; Miller BE; Todd K; Szlam F; Moore RH; Tosone SR
• A novel method to assess platelet inhibition by eptifibatide with thrombelastograph.
  Anesth Analg Volume: 99 Page(s): 1794 - 1799
  12/01/2004 Authors: Katori N; Szlam F; Levy JH; Tanaka KA
• The effects of argatroban on thrombin generation and hemostatic activation in vitro.
  Anesth Analg Volume: 99 Page(s): 1283 - 1289
  11/01/2004 Authors: Tanaka KA; Szlam F; Katori N; Sato N; Vega JD; Levy JH
• Clopidogrel (Plavix) and cardiac surgical patients: implications for platelet function monitoring and postoperative bleeding.
  Platelets Volume: 15 Page(s): 325 - 332
  08/01/2004 Authors: Tanaka KA; Szlam F; Kelly AB; Vega JD; Levy JH
• Isoflurane induces dopamine transporter trafficking into the cell cytoplasm.
  Synapse Volume: 53 Page(s): 68 - 73
  08/01/2004 Authors: Byas-Smith MG; Li J; Szlam F; Eaton DC; Votaw JR; Denson DD
• In vitro effects of antihypertensive drugs on thromboxane agonist (U46619)-induced vasoconstriction in human internal mammary artery.
  Br J Anaesth Volume: 93 Page(s): 257 - 262
  08/01/2004 Authors: Tanaka KA; Szlam F; Katori N; Tsuda A; Levy JH
• Effects of tirofiban on haemostatic activation in vitro.
  Br J Anaesth Volume: 93 Page(s): 263 - 269
  08/01/2004 Authors: Tanaka KA; Katori N; Szlam F; Sato N; Kelly AB; Levy JH
• Antithrombotic effects of Intimatan and heparin
  Volume: 98 Page(s): 58 - 58
  04/01/2004 Authors: Tanaka K; Szlam F; Katori N; Vinten-Johansen J; Cardin A; Levy J
• Clot retraction and fibrinolysis on thrombelastography (R)
  Volume: 98 Page(s): 61 - 61
  04/01/2004 Authors: Katori N; Tanaka K; Szlam F; Levy J
• Dose escalating effects of Intimatan, a heparin cofactor II agonist, on thrombin generation
  Volume: 98 Page(s): 46 - 46
  04/01/2004 Authors: Tanaka K; Szlam F; Katori N; Cardin A; Vinten-Johansen J; Levy J
• The influence of red wine or white wine intake on platelet function and viscoelastic property of blood in volunteers.
  Platelets Volume: 15 Page(s): 37 - 41
  02/01/2004 Authors: Kikura M; Levy JH; Safon RA; Lee MK; Szlam F
• Evaluation of a novel kallikrein inhibitor on hemostatic activation in vitro.
  Thromb Res Volume: 113 Page(s): 333 - 339
  01/01/2004 Authors: Tanaka KA; Szlam F; Katori N; Vega JD; Levy JH
• Quantitative assessment of fibrinogen cross-linking by epsilon aminocaproic acid in patients with end-stage liver disease.
  Liver Transpl Volume: 10 Page(s): 123 - 128
  01/01/2004 Authors: Quach T; Tippens M; Szlam F; Van Dyke R; Levy JH; Csete M
• The vasodilatory effects of hydralazine, nicardipine, nitroglycerin, and fenoldopam in the human umbilical artery.
  Anesth Analg Volume: 96 Page(s): 539 - 544
  02/01/2003 Authors: Sato N; Tanaka KA; Szlam F; Tsuda A; Arias ME; Levy JH
• Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study.
  Anesthesiology Volume: 96 Page(s): 1095 - 1102
  05/01/2002 Authors: Levy JH; Despotis GJ; Szlam F; Olson P; Meeker D; Weisinger A
• The in vitro reversal of histamine-induced vasodilation in the human internal mammary artery.
  Anesth Analg Volume: 93 Page(s): 1453 - 1459
  12/01/2001 Authors: Tsuda A; Tanaka KA; Huraux C; Szlam F; Sato N; Yamaguchi K; Levy JH
• Plasma tryptase in nonimmunologic reactions - Reply
  ANESTHESIOLOGY Volume: 94 Page(s): 181 - 181
  01/01/2001 Authors: Levy JH; Szlam F
• Plasma tryptase in nonimmunologic reactions.
  Anesthesiology Volume: 94 Page(s): 180 - 181
  01/01/2001 Authors: Moss J; Renz C
• Weal and flare responses to intradermal rocuronium and cisatracurium in humans.
  Br J Anaesth Volume: 85 Page(s): 844 - 849
  12/01/2000 Authors: Levy JH; Gottge M; Szlam F; Zaffer R; McCall C
• Clopidogrel on bleeding and transfusion requirements after coronary bypass graft surgery
  ANESTHESIOLOGY Volume: 93 Page(s): U147 - U147
  09/01/2000 Authors: Tanaka KA; Tsuda A; Szlam F; Olson PJ; Levy JH
• Effects of methylene blue on histamine-induced vasodilation in human mammary artery
  ANESTHESIOLOGY Volume: 93 Page(s): U135 - U135
  09/01/2000 Authors: Tsuda A; Tanaka KA; Szlam F; Levy JH
• Reversal of amiodarone-induced vasodilation by nitric oxide pathway inhibitors
  ANESTHESIOLOGY Volume: 93 Page(s): U140 - U140
  09/01/2000 Authors: Tanaka KA; Tsuda A; Yamaguchi K; Szlam F; Levy JH
• The in vitro effects of antithrombin III on the activated coagulation time in patients on heparin therapy.
  Anesth Analg Volume: 90 Page(s): 1076 - 1079
  05/01/2000 Authors: Levy JH; Montes F; Szlam F; Hillyer CD
• Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells.
  Anesthesiology Volume: 92 Page(s): 1074 - 1081
  04/01/2000 Authors: Veien M; Szlam F; Holden JT; Yamaguchi K; Denson DD; Levy JH
• Effects of epinephrine and vasopressin on histamine-induced vasodilation in human mammary artery
  ANESTHESIA AND ANALGESIA Volume: 90 Page(s): SCA58 - SCA58
  04/01/2000 Authors: Tsuda A; Tanaka K; Szlam F; Levy JH
• Alpha-adrenergic effect of fenoldpam on human umbilical artery
  ANESTHESIA AND ANALGESIA Volume: 90 Page(s): U273 - U273
  02/01/2000 Authors: Tsuda A; Tanaka K; Szlam F; Levy JH
• Anti-arrhythmia agents and their effects on human internal mammary artery (IMA)
  ANESTHESIOLOGY Volume: 91 Page(s): U149 - U149
  09/01/1999 Authors: Tanaka K; Tsuda A; Yamaguchi K; Szlam F; Levy JH
• Can antihypertensive therapies reverse internal mammary artery (IMA) spasm?
  ANESTHESIOLOGY Volume: 91 Page(s): U148 - U148
  09/01/1999 Authors: Tsuda A; Tanaka K; Yamaguchi K; Szlam F; Levy JH
• The effects of rapacuronium on histamine release and hemodynamics in adult patients undergoing general anesthesia.
  Anesth Analg Volume: 89 Page(s): 290 - 295
  08/01/1999 Authors: Levy JH; Pitts M; Thanopoulos A; Szlam F; Bastian R; Kim J
• Adenosine A(3)-receptor stimulation attenuates postischemic dysfunction through K(ATP) channels.
  Am J Physiol Volume: 277 Page(s): H228 - H235
  07/01/1999 Authors: Thourani VH; Nakamura M; Ronson RS; Jordan JE; Zhao ZQ; Levy JH; Szlam F; Guyton RA; Vinten-Johansen J
• Reversal of histamine-induced vasodilation in the human internal mammary artery
  BRITISH JOURNAL OF ANAESTHESIA Volume: 82 Page(s): 60 - 60
  06/01/1999 Authors: Huraux C; Makita T; Szlam F; Levy JH
• Superoxide production, risk factors, and endothelium-dependent relaxations in human internal mammary arteries.
  Circulation Volume: 99 Page(s): 53 - 59
  01/05/1999 Authors: Huraux C; Makita T; Kurz S; Yamaguchi K; Szlam F; Tarpey MM; Wilcox JN; Harrison DG; Levy JH
• Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass.
  Anesth Analg Volume: 87 Page(s): 781 - 785
  10/01/1998 Authors: Mochizuki T; Olson PJ; Szlam F; Ramsay JG; Levy JH
• A comparative evaluation of the effects of multiple vasodilators on human internal mammary artery.
  Anesthesiology Volume: 88 Page(s): 1654 - 1659
  06/01/1998 Authors: Huraux C; Makita T; Montes F; Szlam F; Levy JH
• Vascular effects of Org9487 in human mammary arteries, a new short acting muscle relaxant
  ANESTHESIA AND ANALGESIA Volume: 86 Page(s): SCA109 - SCA109
  04/01/1998 Authors: Yamaguchi K; Huraux C; Szlam F; Levy JH
• Is the radial artery a better conduit for coronary revascularization?
  ANESTHESIA AND ANALGESIA Volume: 86 Page(s): SCA63 - SCA63
  04/01/1998 Authors: Yamaguchi K; Huraux C; Weisinger A; Szlam F; Levy JH
• The cardiovascular and histamine releasing properties of Organon 9487
  Volume: 86 Page(s): SCA110 - SCA110
  04/01/1998 Authors: Pitts ME; Thanapolous A; Kim J; Bastian R; Szlam F; Levy JH
• Transgenically produced recombinant human ATIII enhances the antithrombotic effects of heparin in patients undergoing cardiac surgery.
  BLOOD Volume: 90 Page(s): 1318 - 1318
  11/15/1997 Authors: Levy JH; Despotis GJ; Olson P; Weisinger A; Szlam F; Meeker DP
• The vasodilator effects of clevidipine on human internal mammary artery.
  Anesth Analg Volume: 85 Page(s): 1000 - 1004
  11/01/1997 Authors: Huraux C; Makita T; Szlam F; Nordlander M; Levy JH
• The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass.
  Anesth Analg Volume: 85 Page(s): 16 - 22
  07/01/1997 Authors: Kikura M; Levy JH; Michelsen LG; Shanewise JS; Bailey JM; Sadel SM; Szlam F
• Superoxide production, risk factors and endothelium dependent relaxation in human internal mammary arteries
  CIRCULATION Volume: 94 Page(s): 2336 - 2336
  10/15/1996 Authors: Huraux C; Makita T; Kurz S; Szlam F; Harrison DG; Levy JH
• H324/38, a new ultrashort acting calcium channel blocker: Evaluation of its vasodilator effect in vitro
  ANESTHESIOLOGY Volume: 85 Page(s): A123 - A123
  09/01/1996 Authors: Huraux C; Makita T; Szlam F; Nordlander M; Levy JH
• Heparinase I (neutralase) reversal of systemic anticoagulation.
  Anesthesiology Volume: 85 Page(s): 339 - 346
  08/01/1996 Authors: Michelsen LG; Kikura M; Levy JH; Lee MK; Lee KC; Zimmermann JJ; Szlam F
• Vascular effects of histamine and acetylcholine in human internal mammary artery
  BRITISH JOURNAL OF ANAESTHESIA Volume: 76 Page(s): A121 - A121
  06/01/1996 Authors: Huraux C; Makita T; Szlam F; Levy JH
• Anesthetic potency of remifentanil in dogs.
  Anesthesiology Volume: 84 Page(s): 865 - 872
  04/01/1996 Authors: Michelsen LG; Salmenper M; Hug CC; Szlam F; VanderMeer D
• Histamine concentrations and hemodynamic responses after remifentanil.
  Anesth Analg Volume: 80 Page(s): 990 - 993
  05/01/1995 Authors: Sebel PS; Hoke JF; Westmoreland C; Hug CC; Muir KT; Szlam F
• Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery.
  Anesthesiology Volume: 81 Page(s): 616 - 622
  09/01/1994 Authors: Bailey JM; Levy JH; Kikura M; Szlam F; Hug CC
• Anesthetic and hemodynamic interactions of dexmedetomidine and fentanyl in dogs.
  Anesthesiology Volume: 80 Page(s): 837 - 846
  04/01/1994 Authors: Salmenper MT; Szlam F; Hug CC
• Determination of the hemodynamics and histamine release of rocuronium (Org 9426) when administered in increased doses under N2O/O2-sufentanil anesthesia.
  Anesth Analg Volume: 78 Page(s): 318 - 321
  02/01/1994 Authors: Levy JH; Davis GK; Duggan J; Szlam F
• PHARMACOKINETICS OF MILRINONE DURING CARDIAC-SURGERY
  ANESTHESIOLOGY Volume: 79 Page(s): A102 - A102
  09/01/1993 Authors: BAILEY JM; LEVY JH; SZLAM F; HUG CC
• Amrinone in patients undergoing cardiac surgery.
  Anesthesiology Volume: 77 Page(s): 215 - 216
  07/01/1992 Authors: Lathi KG
• Pharmacokinetics of amrinone during cardiac surgery.
  Anesthesiology Volume: 75 Page(s): 961 - 968
  12/01/1991 Authors: Bailey JM; Levy JH; Rogers HG; Szlam F; Hug CC
• The pharmacokinetics and pharmacodynamics of ketamine in dogs anesthetized with enflurane.
  J Pharmacokinet Biopharm Volume: 19 Page(s): 145 - 156
  04/01/1991 Authors: Schwieger IM; Szlam F; Hug CC
• Is lower esophageal contractility a reliable indicator of the adequacy of opioid anesthesia?
  J Clin Monit Volume: 5 Page(s): 164 - 169
  07/01/1989 Authors: Schwieger IM; Hug CC; Hall RI; Szlam F
• Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?
  Anesthesiology Volume: 70 Page(s): 667 - 671
  04/01/1989 Authors: Schwieger IM; Hall RI; Szlam F; Hug CC
• Absence of agonistic or antagonistic effect of flumazenil (Ro 15-1788) in dogs anesthetized with enflurane, isoflurane, or fentanyl-enflurane.
  Anesthesiology Volume: 70 Page(s): 477 - 480
  03/01/1989 Authors: Schwieger IM; Szlam F; Hug CC
• Pharmacokinetics and pharmacodynamics of midazolam in the enflurane-anesthetized dog.
  J Pharmacokinet Biopharm Volume: 16 Page(s): 251 - 262
  06/01/1988 Authors: Hall RI; Szlam F; Hug CC
• The enflurane-sparing effect of alfentanil in dogs.
  Anesth Analg Volume: 66 Page(s): 1287 - 1291
  12/01/1987 Authors: Hall RI; Szlam F; Hug CC
• Dezocine-MAC reduction and evidence for myocardial depression in the presence of enflurane.
  Anesth Analg Volume: 66 Page(s): 1169 - 1174
  11/01/1987 Authors: Hall RI; Murphy MR; Szlam F; Hug CC
• Eicosenoic and docosenoic acid incorporation in serum lipoproteins in rats fed rapeseed oil.
  Lipids Volume: 13 Page(s): 121 - 127
  02/01/1978 Authors: Szlam F; Sgoutas DS
• In vitro incorporation of isomeric cis-octadecenoic acids by rat liver mitochondria.
  Biochim Biophys Acta Volume: 441 Page(s): 14 - 24
  07/20/1976 Authors: Sgoutas D; Jones R; Befanis P